Sortilin is involved in many facets of cardiovascular and metabolic disease pathogenesis, including atherosclerosis, lipoprotein metabolism, vascular calcification, obesity, insulin resistance, and glucose homeostasis. This evidence concerns the gene INS and obesity disorder.